Your browser doesn't support javascript.
loading
An exploratory analysis of factors associated with weight change in a 16-week trial of oral vs. orally disintegrating olanzapine: the PLATYPUS study.
Karagianis, J; Landry, J; Hoffmann, V P; Grossman, L; De Haan, L; Maguire, G; Milev, R; Holt, S.
Afiliação
  • Karagianis J; Eli Lilly Canada Inc., Toronto, ON, CanadaFaculty of Medicine, Discipline of Psychiatry, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, CanadaEli Lilly and Company, Indianapolis, IN, USADepartment of Medicine, Faculty of Medicine, University of Toronto and St. Michael's
  • Landry J; Eli Lilly Canada Inc., Toronto, ON, CanadaFaculty of Medicine, Discipline of Psychiatry, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, CanadaEli Lilly and Company, Indianapolis, IN, USADepartment of Medicine, Faculty of Medicine, University of Toronto and St. Michael's
  • Hoffmann VP; Eli Lilly Canada Inc., Toronto, ON, CanadaFaculty of Medicine, Discipline of Psychiatry, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, CanadaEli Lilly and Company, Indianapolis, IN, USADepartment of Medicine, Faculty of Medicine, University of Toronto and St. Michael's
  • Grossman L; Eli Lilly Canada Inc., Toronto, ON, CanadaFaculty of Medicine, Discipline of Psychiatry, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, CanadaEli Lilly and Company, Indianapolis, IN, USADepartment of Medicine, Faculty of Medicine, University of Toronto and St. Michael's
  • De Haan L; Eli Lilly Canada Inc., Toronto, ON, CanadaFaculty of Medicine, Discipline of Psychiatry, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, CanadaEli Lilly and Company, Indianapolis, IN, USADepartment of Medicine, Faculty of Medicine, University of Toronto and St. Michael's
  • Maguire G; Eli Lilly Canada Inc., Toronto, ON, CanadaFaculty of Medicine, Discipline of Psychiatry, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, CanadaEli Lilly and Company, Indianapolis, IN, USADepartment of Medicine, Faculty of Medicine, University of Toronto and St. Michael's
  • Milev R; Eli Lilly Canada Inc., Toronto, ON, CanadaFaculty of Medicine, Discipline of Psychiatry, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, CanadaEli Lilly and Company, Indianapolis, IN, USADepartment of Medicine, Faculty of Medicine, University of Toronto and St. Michael's
  • Holt S; Eli Lilly Canada Inc., Toronto, ON, CanadaFaculty of Medicine, Discipline of Psychiatry, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, CanadaEli Lilly and Company, Indianapolis, IN, USADepartment of Medicine, Faculty of Medicine, University of Toronto and St. Michael's
Int J Clin Pract ; 64(11): 1520-1529, 2010 Oct.
Article em En | MEDLINE | ID: mdl-20846199
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2010 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2010 Tipo de documento: Article